MTX-001 is also being studied in an ongoing multicenter, Phase 2 double-blind, placebo-controlled trial focused on venous leg ulcers (VLUs). The company is actively expanding collaborations with ...

--Teladoc Health, the global leader in virtual care, today announced the launch of Wellbound, a bold new employee assistance program designed to empower a more engaged, healthier workforce ...